The cranial base in craniofacial development: A gene therapy study

S. Kyrkanides, P. Kambylafkas, J. H. Miller, R. H. Tallents, J. E. Puzas

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


The etiology of midface retrusion remains largely unclear. We hypothesized that the cranial base synchondroses play a key role in the development of the craniofacial skeleton in the Sandhoff mouse model. We observed that developmental abnormalities of the cranial base synchondroses involving proliferative chondrocytes are important in craniofacial growth and development. Neonatal restitution of β-hexosaminidase in mutant mice by gene therapy successfully ameliorated the attendant skeletal defects and restored craniofacial morphology in vivo, suggesting this as a critical temporal window in craniofacial development. Analysis of our data implicates parathyroid-related peptide (PTHrP) and cyclo-oxygenase-2 (COX-2) as possible factors underlying the development of the aforementioned skeletal defects. Hence, timely restitution of a genetic deficiency or, alternatively, the restoration of PTHrP or cyclo-oxygenase activity by the administration of PTH and/or non-steroidal anti-inflammatory drugs or COX-2 selective inhibitors to affected individuals may prove beneficial in the management of midface retrusion.

Original languageEnglish
Pages (from-to)956-961
Number of pages6
JournalJournal of Dental Research
Issue number10
StatePublished - Oct 2007


  • Cartilage
  • Growth plate
  • Lysosomal storage diseases
  • Maxilla
  • Maxillofacial development
  • Sandhoff disease
  • Skull base

ASJC Scopus subject areas

  • Dentistry (all)


Dive into the research topics of 'The cranial base in craniofacial development: A gene therapy study'. Together they form a unique fingerprint.

Cite this